Our latest list of up-and-coming investment strategies includes COWZ, BFRIX, and more. Morningstar Manager Research’s latest ...

The headline safe withdrawal rate from Morningstar’s 2024 retirement income research was dispiriting: We pegged 3.7% as a ...

"It's still a very strong Trump news cycle. The last thing Powell wants to do is to kind of paint a target on the Fed" by suggesting in any way that interest-rate policy "could interfere with the ...

Markets are getting rocked: Dow futures (YM00) are down over 400 points, as the Nasdaq 100 contract (NQ00) skids by 4%. Bond yields dived, with the 10-year Treasury BX:TMUBMUSD10Y falling 10 basis ...

Her son threatened to put her in a nursing home if she didn't send his check by Friday' My fiancé and his sister care for their 100-year-old aunt. She lives alone, but has a sitter at night. She has ...

The Fed will outline a rate decision Wednesday. Due to evidence of a strong U.S. economy, interest rates are widely expected to be kept on hold. Focus will center on any accompanying hints about ...

Companies with good payouts are now the hottest bet in China markets. Banks are hoping to sell the X debt at around 90 to 95 cents on the dollar. Recent court cases reveal how middlemen are ...

Oil futures traded slightly lower Monday morning after President Trump paused steep retaliatory tariffs that he had threatened against Colombia, a key source of U.S. crude imports.

-- Perplexity AI has revised its merger proposal with ByteDance, the parent company of TikTok, that could pave the way for the U.S. government to own a stake, says a CNBC report.

My wife and I own a business, two houses and a commercial building on three parcels of real estate totaling about 56 acres. We have no debts - the real estate was paid off a long time ago, the ...

The dual transaction will include the launch of a new 10-year, February 2035-dated bond, as well as the reopening of the 1.85% May 2049-dated green bond, the same bank said. The banks acting as joint ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...